Experience
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Mylan Pharmaceuticals Inc. et al.
Biogen MA Inc. et al.
Represented patent owner Biogen in inter partes review (IPR) challenge related to Tecfidera® (dimethyl fumarate) for the treatment of multiple sclerosis.
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al., IPR2018-01403, PTAB, Judges Chagnon, Harlow, Snedden
